JPS649932A - Soft capsule preparation using newly combined component as the base - Google Patents
Soft capsule preparation using newly combined component as the baseInfo
- Publication number
- JPS649932A JPS649932A JP62164145A JP16414587A JPS649932A JP S649932 A JPS649932 A JP S649932A JP 62164145 A JP62164145 A JP 62164145A JP 16414587 A JP16414587 A JP 16414587A JP S649932 A JPS649932 A JP S649932A
- Authority
- JP
- Japan
- Prior art keywords
- base material
- cap
- soft capsule
- base
- capsules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
PURPOSE:To provide enteric soft capsules of high efficiency easily by using a base material consisting of polyethylene glycol (PG), cellulose acetate propionate (CAP) or hydroxypropyl methyl cellulose phthalate (HP). CONSTITUTION:The base material is prepared by admixing CAP or HP to PG and its equivalent substance such as squalene at a PG/CAP weight ratio of (70-97):(30-3). The base material is combined with a soft capsule drug to give the subject preparation. The base material according to the present invention is a clear liquid which is a little viscous at room temperature, and becomes a white and opaque solid, and insoluble, when meets water. The soft capsules can be obtained through a simple process in no need of coating such as in case of tablets, even when enteric or gradually releasing capsules are produced.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62164145A JPS649932A (en) | 1987-07-01 | 1987-07-01 | Soft capsule preparation using newly combined component as the base |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62164145A JPS649932A (en) | 1987-07-01 | 1987-07-01 | Soft capsule preparation using newly combined component as the base |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS649932A true JPS649932A (en) | 1989-01-13 |
Family
ID=15787603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62164145A Pending JPS649932A (en) | 1987-07-01 | 1987-07-01 | Soft capsule preparation using newly combined component as the base |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS649932A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994000128A1 (en) * | 1992-06-22 | 1994-01-06 | Lunar Corporation | ORAL 1α-HYDROXYPREVITAMIN D |
WO1994014421A2 (en) * | 1992-12-23 | 1994-07-07 | Saitec S.R.L. | Process for preparing controlled release pharmaceutical forms and the forms thus obtained |
WO1995011024A1 (en) * | 1993-10-19 | 1995-04-27 | The Procter & Gamble Company | Picosulphate dosage form |
JPWO2003072085A1 (en) * | 2002-02-27 | 2005-06-16 | 塩野義製薬株式会社 | Solid formulation with improved absorption of poorly water-soluble drugs |
JP2005531531A (en) * | 2002-04-15 | 2005-10-20 | パリス,ローレンス | Liquid compositions for sustained-release soft capsules and methods for producing them |
EP1940365A2 (en) * | 2005-10-24 | 2008-07-09 | Eastman Chemical Company | Liquid dosage forms having enteric properties of delayed and then sustained release |
JP2011057712A (en) * | 1998-11-04 | 2011-03-24 | Mayne Pharma Plc | Oral administration of adenosine analogue |
-
1987
- 1987-07-01 JP JP62164145A patent/JPS649932A/en active Pending
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994000128A1 (en) * | 1992-06-22 | 1994-01-06 | Lunar Corporation | ORAL 1α-HYDROXYPREVITAMIN D |
WO1994014421A2 (en) * | 1992-12-23 | 1994-07-07 | Saitec S.R.L. | Process for preparing controlled release pharmaceutical forms and the forms thus obtained |
WO1994014421A3 (en) * | 1992-12-23 | 1994-08-18 | Diolaiti Luigi | Process for preparing controlled release pharmaceutical forms and the forms thus obtained |
US5662935A (en) * | 1992-12-23 | 1997-09-02 | Saitec S.R.L. | Process for preparing controlled release pharmaceutical forms and the forms thus obtained |
WO1995011024A1 (en) * | 1993-10-19 | 1995-04-27 | The Procter & Gamble Company | Picosulphate dosage form |
US5631022A (en) * | 1993-10-19 | 1997-05-20 | The Procter & Gamble Company | Picosulfate dosage form |
JP2011057712A (en) * | 1998-11-04 | 2011-03-24 | Mayne Pharma Plc | Oral administration of adenosine analogue |
JPWO2003072085A1 (en) * | 2002-02-27 | 2005-06-16 | 塩野義製薬株式会社 | Solid formulation with improved absorption of poorly water-soluble drugs |
JP4632288B2 (en) * | 2002-02-27 | 2011-02-16 | 塩野義製薬株式会社 | Solid formulation with improved absorption of poorly water-soluble drugs |
JP2005531531A (en) * | 2002-04-15 | 2005-10-20 | パリス,ローレンス | Liquid compositions for sustained-release soft capsules and methods for producing them |
JP4918212B2 (en) * | 2002-04-15 | 2012-04-18 | パリス,ローレンス | Liquid compositions for sustained-release soft capsules and methods for producing them |
EP1940365A2 (en) * | 2005-10-24 | 2008-07-09 | Eastman Chemical Company | Liquid dosage forms having enteric properties of delayed and then sustained release |
JP2009512699A (en) * | 2005-10-24 | 2009-03-26 | イーストマン ケミカル カンパニー | Liquid dosage form with enteric properties of delayed release followed by sustained release |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1033128T3 (en) | Preparation of soft gelatin capsules | |
KR840000228A (en) | Method for preparing dry powder in preparation mixture | |
DK228682A (en) | PROCEDURE FOR MANUFACTURING A PHARMACEUTICAL MEDICINE WITH LONG-TERM RELEASE | |
CA2168732A1 (en) | Gelatin Capsules Containing a Highly Concentrated Acetaminophen Solution | |
NO308828B1 (en) | Pharmaceutical preparation | |
GB8305693D0 (en) | Pharmaceutical compositions | |
NO146456C (en) | PROCEDURE FOR THE PREPARATION OF Capsule Drugs, Especially For Medication Dosage Capsule | |
JPS5770814A (en) | Oral preparation of blood clotting eighth factor | |
DE19375028I2 (en) | Nonapeptide and decapeptide derivatives of the luteinizing hormone releasing hormone, their preparation and pharmaceutical compositions containing them | |
KR910014120A (en) | Oral Pharmaceutical Formulations of Fimovevenan | |
NO874989D0 (en) | PROCEDURE FOR THE PREPARATION OF TABLETS OR CAPSULES CONTAINING A SUPER DESINT Migrant. | |
JPS649932A (en) | Soft capsule preparation using newly combined component as the base | |
IE36611B1 (en) | Propanolamine derivatives their preparation and therapeutic compositions containing the same | |
IL47205A0 (en) | Watersoluble extracts,their preparation and pharmaceutical compositions containing them | |
JPS5442380A (en) | Regenerative capsule | |
ATE21336T1 (en) | GALENIC FORM FOR ORAL ADMINISTRATION AND PROCESS FOR THE PREPARATION THEREOF. | |
EP0276116A3 (en) | Capsule filling | |
IL46539A0 (en) | Esters of dihydroapovincaminic acid,their preparation and pharmaceutical compositions containing them | |
IL47268A (en) | Racemic or optically active 4-acyl-1,3,4,5-tetrahydro-2h-1,4-benzo-diazepin-2-ones,process for their preparation and pharmaceutical compositions containing them | |
IL47207A0 (en) | Watersoluble extracts,their preparation and pharmaceutical compositions containing them | |
JPS5668619A (en) | Nifedipine-containing solid composition | |
JPS52130905A (en) | Medicinal composition | |
JPS60109520A (en) | Multilocular soft capsule agent | |
JPS577410A (en) | Plaster | |
USD216307S (en) | Pharmaceutical tablet |